thalidomide has been researched along with carbostyril in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gidoh, M; Saito, H | 1 |
| Gore, SD | 1 |
| Blum, S; Gattermann, N; Germing, U; Haas, R; Habersang, K; Kuendgen, A; Möller, I | 1 |
| Barosi, G; Rosti, V | 1 |
| Baer, MR; Gojo, I | 1 |
| Brocklehurst, P; Glenny, AM; Gorodkin, R; Pemberton, MN; Riley, P; Taylor, J; Walsh, T | 1 |
| Angelergues, A; Mejean, A; Michel, C; Oudard, S; Tartour, E; Thibault, C; Timsit, MO; Vano, Y | 1 |
| Anderson, E; Barton, P; Burgess, J; Byth, K; Cao, Q; Carbajo, RJ; Castaldi, MP; Chen, H; Cheung, T; Chiarparin, E; Code, E; Cowan, S; Davey, PR; Fawell, S; Ferguson, AD; Fillery, S; Fuller, NO; Gao, N; Hargreaves, D; Howard, MR; Hu, J; Kawatkar, A; Kemmitt, PD; Leo, E; McCoull, W; Molina, DM; O'Connell, N; Petteruti, P; Rasmusson, T; Raubo, P; Rawlins, PB; Ricchiuto, P; Robb, GR; Schenone, M; Waring, MJ; Wilson, DM; Zinda, M | 1 |
3 review(s) available for thalidomide and carbostyril
| Article | Year |
|---|---|
[Present status of studies on antileprosy drugs].
Topics: Animals; Clarithromycin; Dapsone; Drug Therapy, Combination; Humans; Immunologic Factors; Leprostatic Agents; Minocycline; Prothionamide; Quinolones; Rifampin; Rifamycins; Thalidomide | 1995 |
Novel strategies for patients with chronic myeloproliferative disorders.
Topics: Chronic Disease; Humans; Interferon alpha-2; Interferon-alpha; Janus Kinase 2; Mutation; Myeloproliferative Disorders; Nitriles; Primary Myelofibrosis; Pyrazoles; Pyrimidines; Quinolones; Recombinant Proteins; Thalidomide | 2009 |
Interventions for the management of oral ulcers in Behçet's disease.
Topics: Acyclovir; Adrenal Cortex Hormones; Alanine; Behcet Syndrome; Colchicine; Cyclosporine; Etanercept; Humans; Immunoglobulin G; Interferon-alpha; Oral Ulcer; Quinolones; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Stomatitis, Aphthous; Sucralfate; Thalidomide | 2014 |
6 other study(ies) available for thalidomide and carbostyril
| Article | Year |
|---|---|
48th annual meeting of the American Society of Hematology December 9-12, 2006, Orlando, FL.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Disease Progression; Drug Therapy, Combination; Hematologic Diseases; Hematology; Humans; Lenalidomide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Melphalan; Multiple Myeloma; Prednisone; Pyrazines; Quinolones; Recurrence; Stem Cell Transplantation; Thalidomide; Transplantation Conditioning; Transplantation, Autologous | 2007 |
New agents for the treatment of AML recent study findings.
Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Azacitidine; Carbazoles; Clofarabine; Decitabine; Enzyme Inhibitors; Furans; Humans; Hydrazines; Immunotherapy; Lenalidomide; Leukemia, Myeloid, Acute; Quinolones; Staurosporine; Sulfonamides; Thalidomide | 2008 |
Repeated responses of an elderly patient with high-risk myelodysplastic syndrome to sequential therapy with tipifarnib, 5-azacitidine, and decitabine.
Topics: Aged; Anemia, Refractory, with Excess of Blasts; Azacitidine; Benzene; Decitabine; DNA (Cytosine-5-)-Methyltransferases; Drug Therapy, Combination; Farnesyltranstransferase; Histone Deacetylase Inhibitors; Humans; Male; Occupational Exposure; Platelet Count; Quinolones; Thalidomide; Valproic Acid | 2009 |
Novel agents for the treatment of acute myeloid leukemia in the older patient.
Topics: Adenine Nucleotides; Age Factors; Aged; Antineoplastic Agents; Arabinonucleosides; Azacitidine; Clofarabine; Cytosine; Decitabine; Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Leukemia, Myeloid, Acute; Middle Aged; Prognosis; Quinolones; Thalidomide | 2011 |
Topics: Antibodies, Monoclonal; Cancer Vaccines; Cell Cycle Checkpoints; Humans; Immunomodulation; Immunotherapy; Ipilimumab; Lenalidomide; Male; Nivolumab; Programmed Cell Death 1 Receptor; Prostatic Neoplasms; Quinolines; Quinolones; Thalidomide; Tissue Extracts; Vaccines, Synthetic | 2016 |
Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Cell Line, Tumor; HEK293 Cells; Humans; Ligands; Lymphoma, Large B-Cell, Diffuse; Peptide Hydrolases; Protein Binding; Proteolysis; Proto-Oncogene Proteins c-bcl-6; Quinolones; Thalidomide; Ubiquitin-Protein Ligases | 2018 |